Three Blood p-tau217 Tests All Nailed Alzheimer’s Diagnosis
TL;DR: A 2026 study in Translational Psychiatry found that three different plasma p-tau217 assays separated Alzheimer’s dementia from controls and frontotemporal degeneration with excellent accuracy, shifting the test from whether the marker works to which platform clinics can deploy. Key Findings Three p-tau217 assays all performed strongly: The cohort included 39 cognitively unimpaired controls, 28 …
